Alpha Tau Medical Ltd

Market Cap

$865M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.28+$4.45 (+92.13%)

Jun 8, 2026

52W High $11.1852W Low $2.90

Company Details

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT...

CEO

—

IPO Date

Mar 8, 2021

Website

www.alphatau.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$57M

EPS (Diluted)

Free Cash Flow

-$33M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 19, 2026

FY 2025

Mar 9, 2026

Q4 2025

Mar 9, 2026

Q3 2025

Nov 20, 2025

Q2 2025

Aug 11, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee